Furnish data on malnutrition in 4 weeks: HC tells MP govt
The bench, comprising Chief Justice Sanjeev Sachdeva and Justice Vinay Saraf, gave four weeks for this purpose and issued notices to the state govt and the chief secretary in response to a Public Interest Litigation (PIL) moved by a resident of Jabalpur, Deepankar Singh.
Singh, in his petition, said that there is an alarming situation in MP regarding malnutrition among its people, but the state govt keeps hiding this terrible state of affairs by 'manipulating' data.
He requested the court to ask for a report on malnutrition from the state govt to know the actual state of malnutrition prevalent among the people in MP so that efforts could be made to tackle the menace of malnutrition, particularly among the children.
He said that according to the Poshan Tracker-2.0 and National Health Survey report, MP stands second in the country in terms of malnutrition. Attributing this situation to poor implementation of schemes on health and nutrition, he said that weak, underweight, and stunted children are born in the state because of malnutrition.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
You will never turn off your computer again.
planetcapture.io
Undo
He further said that CAG, in its report, referred to a massive scam in the transportation and quality of nutritious food, but there was no action on the part of the state govt.
The petitioner said that among 66 lakh children in the age group of 0 to 6 years, 10 lakh are malnourished, and 1.36 lakh of them are severely malnourished. The prevalence of anaemia among women is 57%. It was also pointed out during the hearing that Rs 1.80 crore were paid as rent for anganwadi centres in Jabalpur district alone, but only a handful of children visit those centres.
After the initial hearing, the court asked all the district collectors from across the state to furnish a report on the status of malnutrition in their respective districts within four weeks. Advocate Amit Singh Sengar and Atul Jain appeared in the case for the petitioner.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
&w=3840&q=100)
Business Standard
28 minutes ago
- Business Standard
Govt scheme helps Indians save money on medicines: You can benefit, too
Medicine costs can weigh heavily on household budgets, especially for those managing chronic conditions. But the government says that its scheme is helping Indians manage such costs. Jan Aushadhi Kendras (JAKs) have helped citizens to save around Rs 38,000 crore in 11 years, according to data presented to Parliament by the Ministry of Chemicals and Fertilisers. There were 16,912 Jan Aushadhi stores nationwide as of June, providing affordable generic medicines and surgical products, according to a PTI report. What is the Jan Aushadhi scheme? Launched in 2008 and revamped in 2015, the Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) aims to make quality medicines available at affordable prices. Generic drugs, sold under their chemical name rather than a brand, are said to be just as effective as their branded counterparts. According to PMBJP's website, the scheme covers: -2,110 medicines and 315 surgical products -61 surgical equipment categories -Medicines priced 50-80 per cent lower than popular branded options Health care costs PTI reported, Anupriya Patel, Minister of State for Health and Family Welfare, told Rajya Sabha the scheme has helped people to reduce their out-of-pocket expenses on health. According to data from National Health Accounts, such expenses fell from 62.6 per cent of total health expenditure in 2014-15 to 39.4 per cent in 2021-22. The government now plans to expand the network to 25,000 kendras by March 2027. Branded vs Jan Aushadhi: A quick comparison A look at the price list of common medicines shows the steep difference between Jan Aushadhi and branded products: Medicine Name Jan Aushadhi Price (₹) Popular Brand Price (₹) Telmisartan 40mg (BP) 2.26 (per tab) 10–12 Metformin 500mg 1.06 (per tab) 4–6 Atorvastatin 10mg 3.19 (per tab) 7–10 Pantoprazole 40mg 2.20 (per tab) 6–8 Amoxicillin 500mg 1.80 (per cap) 5–7 Paracetamol 500mg 0.7 (per tab) 1-3 Source: Jan Aushadhi price list, 30 July 2025; market rates from pharmacy portals Should you switch? If you're managing long-term health conditions like diabetes, hypertension, or acidity, switching to Jan Aushadhi equivalents could lead to monthly savings. However, always consult your doctor before switching brands, as not all formulations may be identical in inactive ingredients or in dosage form.
Time of India
36 minutes ago
- Time of India
What makes the heartbeat stop at night? Know the silent symptoms you might miss
In today's stressful and fast-paced lifestyle, Chronic Heart Failure (CHF) has become a rising health concern. Unlike sudden heart attacks, CHF develops gradually and often goes unnoticed until it becomes severe. What makes this condition especially dangerous is its tendency to worsen at night, when the body is at rest and the heart works differently compared to waking hours. During sleep, reduced heart function can trigger breathlessness, fluid accumulation, and even life-threatening cardiac events. Understanding why CHF poses greater risks during sleep, how to recognize early warning signs, and adopting preventive measures can save lives. Why heart failure risks increase during sleep At night, when a person lies down, body fluids naturally shift from the legs to the chest, increasing pressure on the lungs and heart. In patients with heart failure, this fluid redistribution worsens breathing difficulties and strains the already weakened heart. This condition is often experienced as paroxysmal nocturnal dyspnea (PND) – waking up suddenly, gasping for breath – or orthopnea, which is difficulty breathing when lying flat. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Use an AI Writing Tool That Actually Understands Your Voice Grammarly Install Now Undo Slower heart rate – During sleep, the heart beats slower, reducing its pumping efficiency in those with weakened heart muscles. Fluid overload – Nighttime urine production increases in CHF patients, causing frequent urination and disrupted sleep patterns. Oxygen fluctuations – Conditions like sleep apnea, common among CHF patients, can further reduce oxygen levels, worsening heart strain. Early symptoms of chronic heart failure that appear at night Many initial signs of chronic heart failure become more noticeable while sleeping: Shortness of breath while lying flat – Needing multiple pillows or sleeping in a recliner to breathe comfortably. Frequent Nighttime Urination (Nocturia) – Waking up several times to urinate due to fluid accumulation. Sudden nighttime breathlessness (PND) – Waking up gasping for air. Irregular heartbeats and chest tightness – Often more prominent at night when the body is at rest. Fatigue upon waking – Despite a full night's sleep, waking up exhausted due to poor heart function and reduced oxygen supply. Ignoring these symptoms can lead to sudden cardiac complications, highlighting the importance of seeking timely medical attention. Are men more vulnerable to nighttime heart risks Studies show that before age 45, men are at a higher risk of developing chronic heart failure. However, after the age of 50, men and women face equal risk, particularly at night. Hormonal changes in women after menopause increase their vulnerability to cardiovascular diseases, making nighttime monitoring important for both genders. Stages of heart failure and nighttime impact Stage 1 – Early stage Mild symptoms, often unnoticed during the day, may first appear at night as occasional breathlessness or increased urination. Stage 2 & 3 – Moderate heart failure Shortness of breath while lying down becomes common. Patients may need multiple pillows to sleep or wake up coughing and gasping. Stage 4 – Severe heart failure Sleep becomes severely disrupted; patients often cannot sleep flat and experience repeated nighttime cardiac distress. In such cases, hospital-based interventions or even a heart transplant may be required. How to protect your heart during sleep Sleep with head elevated – Using extra pillows or an adjustable bed reduces fluid shift and eases breathing. Monitor fluid intake – Avoid excess liquids before bedtime to reduce nighttime fluid buildup and urination. Control salt consumption – Reducing sodium decreases water retention, easing heart workload. Maintain healthy sleep patterns – Go to bed and wake up at consistent times to regulate cardiovascular function. Regular checkups – Monitor heart function and sleep quality, especially if symptoms worsen at night. Lifestyle changes for better nighttime heart health Exercise regularly – Light activities like walking or yoga improve overall heart function. Avoid smoking and alcohol – Both substances disrupt sleep and weaken the heart. Stress management – Techniques like meditation and deep breathing can prevent nighttime blood pressure spikes. Periodic sleep studies – Identifying hidden sleep disorders like sleep apnea helps in reducing nighttime cardiac risk. Important tip: Chronic Heart Failure is often called a 'silent killer' because it creeps up slowly and causes most damage when the body is resting. Nighttime symptoms, such as sudden breathlessness, frequent urination, and disturbed sleep, are critical warning signs that should never be ignored. By understanding the nighttime risks and adopting lifestyle modifications, patients can improve both heart health and sleep quality, significantly reducing life-threatening complications. Also Read | Magnesium may be the missing nutrient your brain needs to fight brain fog and boost focus naturally
Time of India
an hour ago
- Time of India
Who is Audrey Crews? Paralysed woman writes her name after 20 years using Elon Musk's Neuralink brain chip
Source: X (Audrey Crews) In a groundbreaking medical and technological milestone, Audrey Crews, a woman paralysed for 20 years, has become the first Neuralink patient to publicly demonstrate thought-based computer control. With the help of a brain chip developed by Elon Musk 's Neuralink, Crews successfully moved a digital cursor and signed her name on a computer screen—using nothing but her thoughts. Her achievement, revealed through a viral social media post, not only showcases Neuralink's cutting-edge brain-computer interface (BCI) technology but also offers a glimpse into a future where individuals with paralysis may regain independence in ways previously unimaginable. Audrey Crews' achievement is more than a technological demonstration—it is a symbol of hope for millions living with paralysis. With Neuralink pushing boundaries, we are witnessing the early steps toward a future where physical disability does not limit a person's ability to connect, communicate, and create. Who is Audrey Crews and why is this moment historic Audrey Crews, also known as 'Patient P9' in Neuralink's clinical trial program, had lived with complete paralysis for two decades due to a severe spinal cord injury. Earlier this month, she underwent a brain chip implant procedure at the University of Miami Health Centre. Shortly after surgery, she shared an image on X (formerly Twitter) showing her digitally signed name with the caption: 'I tried writing my name for the first time in 20 years.' Her post quickly went viral and was confirmed by Elon Musk, who wrote: 'She is controlling the computer entirely by thought.' This demonstration represents a pivotal moment in medical neurotechnology, similar in significance to the first use of prosthetic limbs or cochlear implants. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like 11 Harry Potter Actors Who Grew Up Stunningly. The Noodle Box Read More Undo What is Neuralink and how does it work Founded in 2016 by Elon Musk, Neuralink is developing brain-computer interfaces (BCIs)—devices designed to establish a direct communication link between the human brain and external machines. Neuralink's three product goals: Telepathy – A BCI enabling individuals with physical disabilities to control computers and devices through neural signals. Blindsight – A vision restoration system bypassing damaged optic nerves by stimulating the brain's visual cortex. Deep – A neuromodulation platform aimed at managing conditions such as Parkinson's disease and epilepsy. By decoding brain signals and transmitting them wirelessly, these interfaces can allow paralyzed individuals to type, move robotic arms, operate wheelchairs, and potentially regain mobility. Neuralink has now implanted its device in at least five human participants, each showing the ability to control external systems purely through thought. How does the Neuralink brain chip function The Neuralink chip consists of ultra-thin electrode threads surgically implanted into specific regions of the brain responsible for motor control. Signal collection: The electrodes pick up electrical activity generated by neurons during movement intention. AI decoding: Advanced machine learning algorithms decode these neural signals in real time, identifying the user's intended action. Wireless transmission: The interpreted data is transmitted to a computer, where it translates into specific commands like moving a cursor, typing, or even controlling robotic limbs. In Audrey's case, this technology allowed her to move a digital cursor and write her signature—tasks she had been unable to perform for 20 years. Why is this a breakthrough for people with paralysis For individuals living with paralysis, everyday tasks such as writing, typing, or even using a smartphone become impossible without assistance. Neuralink's brain chip offers hope by bypassing damaged spinal cord pathways and directly linking thoughts to actions. Independence: Users can communicate, work, and interact with digital systems without physical movement. Rehabilitation potential: With future iterations, patients might control wheelchairs, exoskeletons, or prosthetic limbs. Medical insights: The data collected could deepen our understanding of neurological disorders and pave the way for targeted therapies. What's next for Neuralink The company is still in its early clinical trial phase, focusing on ensuring safety, reliability, and accuracy of its implants. The roadmap includes expanding to more patients and exploring applications beyond paralysis, such as restoring vision and treating neurological diseases. Elon Musk has emphasized that Neuralink aims to make brain-computer interfaces as common as LASIK eye surgery within the next decade. If successful, the implications for healthcare, human-machine interaction, and even general computing could be revolutionary. Also Read | Watch | Hawaii resident captures rare Tsunami siren after massive Russia earthquake: 'Never heard this in 11 years'
